{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:23:30Z","timestamp":1783488210846,"version":"3.55.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,2,12]],"date-time":"2014-02-12T00:00:00Z","timestamp":1392163200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s00259-013-2684-4","type":"journal-article","created":{"date-parts":[[2014,2,11]],"date-time":"2014-02-11T16:35:35Z","timestamp":1392136535000},"page":"1166-1171","source":"Crossref","is-referenced-by-count":26,"title":["Radiolabelled GLP-1 receptor antagonist binds to GLP-1 receptor-expressing human tissues"],"prefix":"10.1007","volume":"41","author":[{"given":"Beatrice","family":"Waser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Claude","family":"Reubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,2,12]]},"reference":[{"key":"2684_CR1","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","volume":"87","author":"JJ Holst","year":"2007","unstructured":"Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev 2007;87:1409\u201339.","journal-title":"Physiol Rev"},{"key":"2684_CR2","doi-asserted-by":"crossref","first-page":"736","DOI":"10.2967\/jnumed.106.038679","volume":"48","author":"M K\u00f6rner","year":"2007","unstructured":"K\u00f6rner M, St\u00f6ckli M, Waser B, Reubi JC. GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting. J Nucl Med 2007;48:736\u201343.","journal-title":"J Nucl Med"},{"key":"2684_CR3","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00259-003-1184-3","volume":"30","author":"JC Reubi","year":"2003","unstructured":"Reubi JC, Waser B. Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting. Eur J Nucl Med Mol Imaging 2003;30:781\u201393.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2684_CR4","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.mce.2008.08.012","volume":"297","author":"JJ Holst","year":"2009","unstructured":"Holst JJ, Vilsb\u00f8ll T, Deacon CF. The incretin system and its role in type 2 diabetes mellitus. Mol Cell Endocrinol 2009;297:127\u201336.","journal-title":"Mol Cell Endocrinol"},{"key":"2684_CR5","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nrd3148","volume":"9","author":"DJ Drucker","year":"2010","unstructured":"Drucker DJ, Dritselis A, Kirkpatrick P. Liraglutide. Nat Rev Drug Discov 2010;9:267\u20138.","journal-title":"Nat Rev Drug Discov"},{"key":"2684_CR6","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.2967\/jnumed.110.085142","volume":"52","author":"D Wild","year":"2011","unstructured":"Wild D, Christ E, Caplin M, Kurzawinski TR, Forrer F, Br\u00e4ndle M, et al. Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas. J Nucl Med 2011;52:1073\u20138.","journal-title":"J Nucl Med"},{"key":"2684_CR7","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.ecl.2010.09.003","volume":"39","author":"E Christ","year":"2010","unstructured":"Christ E, Wild D, Reubi JC. Glucagonlike peptide-1 receptor: an example of translational research in insulinomas: a review. Endocrinol Metab Clin North Am 2010;39:791\u2013800.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2684_CR8","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1210\/jc.2009-1082","volume":"94","author":"E Christ","year":"2009","unstructured":"Christ E, Wild D, Forrer F, Br\u00e4ndle M, Sahli R, Clerici T, et al. Glucagon-like peptide-1 receptor imaging for localization of insulinomas. J Clin Endocrinol Metab 2009;94:4398\u2013405.","journal-title":"J Clin Endocrinol Metab"},{"key":"2684_CR9","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1056\/NEJMc0802045","volume":"359","author":"D Wild","year":"2008","unstructured":"Wild D, M\u00e4cke H, Christ E, Gloor B, Reubi JC. Glucagon-like peptide 1-receptor scans to localize occult insulinomas. N Engl J Med 2008;359:766\u20138.","journal-title":"N Engl J Med"},{"key":"2684_CR10","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s00259-012-2299-1","volume":"40","author":"A Sowa-Staszczak","year":"2013","unstructured":"Sowa-Staszczak A, Pach D, Miko\u0142ajczak R, M\u00e4cke H, Jabrocka-Hybel A, Stefa\u0144ska A, et al. Glucagon-like peptide-1 receptor imaging with [Lys40(Ahx-HYNIC- 99mTc\/EDDA)NH2]-exendin-4 for the detection of insulinoma. Eur J Nucl Med Mol Imaging 2013;40:524\u201331.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2684_CR11","doi-asserted-by":"crossref","unstructured":"Christ E, Wild D, Ederer S, B\u00e9h\u00e9 M, Nicolas G, Caplin ME, et al. Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study. Lancet Diabetes Endocrinol 2013;1:115\u201322.","DOI":"10.1016\/S2213-8587(13)70049-4"},{"key":"2684_CR12","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/cmmi.475","volume":"7","author":"M Brom","year":"2012","unstructured":"Brom M, Joosten L, Oyen WJ, Gotthardt M, Boerman OC. Radiolabelled GLP-1 analogues for in vivo targeting of insulinomas. Contrast Media Mol Imaging 2012;7:160\u20136.","journal-title":"Contrast Media Mol Imaging"},{"key":"2684_CR13","doi-asserted-by":"crossref","first-page":"936","DOI":"10.2967\/jnumed.108.061457","volume":"50","author":"B Waser","year":"2009","unstructured":"Waser B, Tamma ML, Cescato R, Maecke HR, Reubi JC. Highly efficient in vivo agonist-induced internalization of sst2 receptors in somatostatin target tissues. J Nucl Med 2009;50:936\u201341.","journal-title":"J Nucl Med"},{"key":"2684_CR14","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.2967\/jnumed.111.088922","volume":"52","author":"D Wild","year":"2011","unstructured":"Wild D, Fani M, Behe M, Brink I, Rivier J, Reubi JC, et al. First clinical evidence that imaging with somatostatin receptor antagonists is feasible. J Nucl Med 2011;52:1412\u20137.","journal-title":"J Nucl Med"},{"key":"2684_CR15","doi-asserted-by":"crossref","first-page":"318","DOI":"10.2967\/jnumed.107.045054","volume":"49","author":"R Cescato","year":"2008","unstructured":"Cescato R, Maina T, Nock B, Nikolopoulou A, Charalambidis D, Piccand V, et al. Bombesin receptor antagonists may be preferable to agonists for tumor targeting. J Nucl Med 2008;49:318\u201326.","journal-title":"J Nucl Med"},{"key":"2684_CR16","doi-asserted-by":"crossref","first-page":"16436","DOI":"10.1073\/pnas.0607761103","volume":"103","author":"M Ginj","year":"2006","unstructured":"Ginj M, Zhang H, Waser B, Cescato R, Wild D, Wang X, et al. Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumors. Proc Natl Acad Sci U S A 2006;103:16436\u201341.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2684_CR17","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.2337\/diab.42.11.1678","volume":"42","author":"B Thorens","year":"1993","unstructured":"Thorens B, Porret A, B\u00fchler L, Deng SP, Morel P, Widmann C. Cloning and functional expression of the human islet GLP-1 receptor. Demonstration that exendin-4 is an agonist and exendin-(9\u201339) an antagonist of the receptor. Diabetes 1993;42:1678\u201382.","journal-title":"Diabetes"},{"key":"2684_CR18","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.bbrc.2009.09.014","volume":"389","author":"E Mukai","year":"2009","unstructured":"Mukai E, Toyoda K, Kimura H, Kawashima H, Fujimoto H, Ueda M, et al. GLP-1 receptor antagonist as a potential probe for pancreatic beta-cell imaging. Biochem Biophys Res Commun 2009;389:523\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"2684_CR19","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1007\/s00259-010-1701-0","volume":"38","author":"B Waser","year":"2011","unstructured":"Waser B, Reubi JC. Value of the radiolabelled GLP-1 receptor antagonist exendin(9\u201339) for targeting of GLP-1 receptor-expressing pancreatic tissues in mice and humans. Eur J Nucl Med Mol Imaging 2011;38:1054\u20138.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2684_CR20","doi-asserted-by":"crossref","first-page":"5434","DOI":"10.1158\/1078-0432.CCR-12-3490","volume":"19","author":"E K\u00e4hk\u00f6nen","year":"2013","unstructured":"K\u00e4hk\u00f6nen E, Jambor I, Kemppainen J, Lehti\u00f6 K, Gr\u00f6nroos TJ, Kuisma A, et al. In vivo imaging of prostate cancer using [68Ga]-labeled bombesin analog BAY86-7548. Clin Cancer Res 2013;19:5434\u201343.","journal-title":"Clin Cancer Res"},{"key":"2684_CR21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11307-011-0481-7","volume":"14","author":"BM Connolly","year":"2012","unstructured":"Connolly BM, Vanko A, McQuade P, Guenther I, Meng X, Rubins D, et al. Ex vivo imaging of pancreatic beta cells using a radiolabeled GLP-1 receptor agonist. Mol Imaging Biol 2012;14:79\u201387.","journal-title":"Mol Imaging Biol"},{"key":"2684_CR22","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.2967\/jnumed.111.095778","volume":"52","author":"R Cescato","year":"2011","unstructured":"Cescato R, Waser B, Fani M, Reubi JC. Evaluation of 177Lu-DOTA-sst2 antagonist versus 177Lu-DOTA-sst2 agonist binding in human cancers in vitro. J Nucl Med 2011;52:1886\u201390.","journal-title":"J Nucl Med"},{"key":"2684_CR23","first-page":"375","volume":"47","author":"L Bodei","year":"2006","unstructured":"Bodei L, Paganelli G, Mariani G. Receptor radionuclide therapy of tumors: a road from basic research to clinical applications. J Nucl Med 2006;47:375\u20137.","journal-title":"J Nucl Med"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-013-2684-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-013-2684-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-013-2684-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T16:06:16Z","timestamp":1558713976000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-013-2684-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,12]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["2684"],"URL":"https:\/\/doi.org\/10.1007\/s00259-013-2684-4","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,12]]}}}